Related Experiment Video
Updated: Jan 30, 2026

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells
Published on: October 11, 2012
Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapies
Léa Dousset1, Katia Boniface2, Julien Seneschal3,2
1Department of Dermatology and Pediatric Dermatology, National Center for Rare Skin Disorders, Saint-André and Pellegrin Hospitals, Bordeaux, France.
Abstract:
Antibody-based therapeutics targeting programmed cell death 1 (PD-1) have shown strong efficacy in the treatment of metastatic cancers as melanoma. However, restoring the immune function with these therapies to target cancer cells leads to immune side effects including immune cutaneous events. Vitiligo-like lesions in patients receiving anti-PD-1 is one of the most common skin adverse event reported and the incidence seems to be higher than in patients receiving other immune-checkpoints therapies. Initially described in patients with metastatic melanoma, vitiligo-like lesions have now been reported in other metastatic cancers treated with anti-PD-1. Several reports suggest that this side effect could be different from spontaneously occurring vitiligo and could be associated with increased response to the therapy and patients' survival. The aim of this review is to provide an overview of the clinical presentation of vitiligo-like lesions occurring in patients receiving anti-PD-1, and the hypothesis to explain the mechanism involved in the development of these lesions.
Insights
Vitiligo-like lesions are common skin side effects of anti-programmed cell death 1 (PD-1) cancer therapies. These lesions may indicate a better response to immunotherapy and improved patient survival.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Antibody-based therapies targeting programmed cell death 1 (PD-1) are effective against metastatic cancers like melanoma.
- Restoring immune function with anti-PD-1 therapies can cause immune-related adverse events, including cutaneous events.
- Vitiligo-like lesions are a frequent skin adverse event associated with anti-PD-1 treatment, potentially more common than with other immunotherapies.
Purpose of the Study:
- To review the clinical presentation of vitiligo-like lesions in patients treated with anti-PD-1 therapies.
- To explore hypothesized mechanisms underlying the development of these lesions.
- To discuss the potential association between vitiligo-like lesions and therapeutic response/patient survival.
Main Methods:
- Literature review of clinical reports and studies on vitiligo-like lesions in patients receiving anti-PD-1 therapy.
- Analysis of the incidence and clinical characteristics of these lesions across various metastatic cancers.
- Synthesis of proposed immunological mechanisms potentially driving lesion development.
Main Results:
- Vitiligo-like lesions are increasingly reported in patients with metastatic cancers treated with anti-PD-1 agents.
- These lesions may differ from spontaneous vitiligo and have been linked to enhanced anti-tumor response.
- Emerging evidence suggests a correlation between these lesions and improved patient survival outcomes.
Conclusions:
- Vitiligo-like lesions are a significant cutaneous manifestation of anti-PD-1 therapy.
- Understanding the mechanisms behind these lesions could offer insights into immunotherapy efficacy.
- Further research is warranted to elucidate the prognostic implications of these lesions in cancer patients.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Receiver Operating Characteristic Plot
Errors occurring during blood pressure monitoring
Several factors...

